By contrast, in patients with acromegaly and CS we recommend not using sulfonylureas and thiazolidinediones and we suggest using metformin combined with GLP-1 RA as the first-line therapy, and in cases of inadequate glycaemic control, SGLT2i could be indicated. The gene discussed is GLP1R; the disease is acromegaly.